The favorable effect of tomato-products rich in lycopene is due to their ability to suppress oxidative stress and to decrease the risk of chronic conditions, such as coronary heart disease, osteoporosis and type II diabetes. Its association with the decreased incidence of prostate and breast cancer has also been well established.
Now a recent study carried by Drs. Herzel Salman, and Michael Bergman of the Department of Internal Medicine C, and Dr. Hannah Besler, senior researcher, under the direction of Prof. Meir Djaldetti at Hasharon Hospital Rabin Medical Center, examined the effect of lycopene on other malignant cell lines. Their findings were indeed promising, indicating that high levels of lycopene repressed the proliferation capacity of human colon carcinoma, myeloid leukemia and lymphoma cell lines. Their findings were published in the international scientific journal "Biomedicine & Pharmacotherapy" and will be further elaborated in the future. Any and all hope to help in the fight against cancer is indeed a step in the right direction.